Circumventing Patent Rights for COVID-19 Vaccines- An Endeavour for Equity in

Healthcare

Abstract
The COVID-19 pandemic will be remembered in the history of humanity as a blot which
tested every human being on multiple levels, both physically and mentally. The quest for
inventing the vaccine for combating this deadly virus began even before the World Health
Organization declared it as a global pandemic in March, 2021. Even though the nature of the
virus, whether it is naturally occurring or a man-made mayhem, is still highly debated, the
grant of patents for the COVID-19 vaccines is another battleground. The patent rights are
exclusive for the creators of drugs and vaccines

A “patent” is granted to an innovator for an idea or innovation which is novel and has the
ability to be

Doha declaration
DNVMs
TRIPS agreement
Covishield+covaxin patent
Pros and cons
Conclusion